Esketamine Nasal Spray Plus Oral Antidepressant in Patients With Treatment-Resistant Depression

  • Wajs E
  • Aluisio L
  • Holder R
  • et al.
N/ACitations
Citations of this article
68Readers
Mendeley users who have this article in their library.

Abstract

This issue of Focus on Suicide brings us new data about risk assessment, with 2 articles examining the utility of rating scales for assessment of suicidal behavior. Youngstrom et al conduct a careful comparison of 3 suicide rating scales: the Columbia Suicide Severity Rating Scale (C-SSRS), the Suicide Tracking Scale (STS), and the Sheehan Suicidality Tracking Scale (S-STS). While the scales did comparably in 2 broad categories, suicidal ideation and suicide attempts, the study suggests that some subtypes of suicidal behavior/ideation are not captured as well by the S-STS.

Cite

CITATION STYLE

APA

Wajs, E., Aluisio, L., Holder, R., Daly, E. J., Lane, R., Lim, P., … Singh, J. B. (2020). Esketamine Nasal Spray Plus Oral Antidepressant in Patients With Treatment-Resistant Depression. The Journal of Clinical Psychiatry, 81(3). https://doi.org/10.4088/jcp.19m12891

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free